Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MØRE SMERTEKLINIKK AS
AS
Active
Org 982528666
Holmen 7A, 6100 Volda
Medical specialists activities · NACE 8622
Est. 2000
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 2,5M
+8% vs 2023
EBITDA margin
67.6%
+19% vs 2023
Equity ratio
74.1%
Financial strength
Net profit 2024
NOK 1,5M
+20% vs 2023
EBITDA — year on year
NOK millions
3M
2M
1M
1M
0M
1M
2020
1M
0%
2021
1M
0%
2022
1M
0%
2023
2M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 2,5M
+8%
EBITDA
NOK 1,7M
+19%
Net profit
NOK 1,5M
+20%
Total assets
NOK 5,1M
+17%
Equity
NOK 3,7M
+22%
Employees
1
—
Company information
Legal name
MØRE SMERTEKLINIKK AS
Org number
982528666
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
2. november 2000
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styreleiar åleine.
Company purpose
Smerteklinikk og annan privat legepraksis, og dessutan anna verksemd som naturleg fell inn under legeverksemd.
Contact
Address
Holmen 7A, 6100 Volda
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Volda
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
3M
2M
2020
2M
2021
2M
2022
2M
2023
3M
2024
EBITDA
NOK millions
0M
1M
1M
2M
2M
1M
2020
1M
2021
1M
2022
1M
2023
2M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 890
2 069
2 168
2 362
2 548
Staff expenses
−495
−368
−438
−487
−516
EBITDA
1 110
1 415
1 407
1 454
1 724
Depreciation & amort.
−34
−34
−34
−34
−41
EBIT
1 076
1 380
1 373
1 419
1 683
Net financials
2
17
27
142
194
Profit before tax
1 078
1 398
1 400
1 561
1 877
Tax
237
306
311
338
404
Net profit
841
1 092
1 089
1 223
1 473
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
3 040
3 456
3 840
4 302
5 054
Equity
1 966
2 358
2 647
3 070
3 743
Long-term debt
0
0
0
0
0
Short-term debt
1 074
1 098
1 193
1 232
1 310
Total debt
1 074
1 098
1 193
1 232
1 310
Financial ratios
5-year trend
EBITDA margin
67.6%
This company
15.8%
Market median
+328% vs market
2020
2024
Equity ratio
74.1%
This company
38.2%
Market median
+94% vs market
2020
2024
Return on equity
39.4%
This company
18.4%
Market median
+114% vs market
2020
2024
Net profit margin
57.8%
This company
8.1%
Market median
+614% vs market
2020
2024
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
2020
2024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
MV
Merete Vartdal Heggedal
Deputy Member
Deputy Member
2000
RH
Rune Heggedal
Chief Executive Officer
Chief Executive Officer
2000
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MØRE SMERTEKLINIKK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Merete Vartdal Heggedal
Deputy Member
0 companies
Rune Heggedal
Chief Executive Officer
0 companies